Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | TACR3 | P29371 | 1/20 | 0.45 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.43 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2114760 | 0.86 | L3MBTL1 (0.54) | RAB9AALDH1A1KMT2AMEN1TFPI2 | |
| SCHEMBL8530895 | 0.84 | KDM1A (0.49) | KDM1AMAOARCOR1NPC1RAB9A | |
| SCHEMBL13309267 | 0.83 | NPC1 (0.48) | KDM1AMAOARCOR1NPC1RAB9A | |
| SCHEMBL9572545 | 0.83 | KDM1A (0.57) | KDM1AMAOARCOR1ALDH1A1KMT2A | |
| SCHEMBL16399234 | 0.83 | TACR3 (0.53) | KDM1AMAOARCOR1NPC1RAB9A | |
| SCHEMBL29123347 | 0.82 | SRD5A1 (0.44) | NPC1RAB9AALDH1A1KMT2AMEN1 | |
| SCHEMBL9027466 | 0.82 | ALDH1A1 (0.49) | KDM1AMAOARCOR1NPC1RAB9A | |
| SCHEMBL30688566 | 0.81 | KMT2A (0.71) | KDM1AMAOARCOR1ALDH1A1KMT2A | |
| SCHEMBL2253255 | 0.81 | ALDH1A1 (0.49) | KDM1AMAOARCOR1ALDH1A1KMT2A | |
| SCHEMBL10845805 | 0.81 | KDM1A (0.45) | KDM1AMAOARCOR1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235319-A1 | NEAR-INFRARED LIGHT-EMITTING DIODE AND DEVICE INCLUDING NEAR-INFRARED LIGHT-EMITTING DIODE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-23 | — | — | US | disclosed |
| EP-0460679-B1 | Endothelin antagonistic peptide derivatives | BANYU PHARMA CO LTD (JP) | 1998-10-28 | — | — | EP | disclosed |
| US-5691315-A | CARDIOVASCULAR DISORDERS; VASODILATOR; BRONCHODILATOR | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1997-11-25 | — | — | US | disclosed |
| US-5470833-A | Vasodilators, bronchodilators | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-11-28 | — | — | US | disclosed |
| US-5444152-A | Vasolidator or bronchodilator | BANYU PHARMACEUTICAL CO., LTD. (JP) | 1995-08-22 | — | — | US | disclosed |
| EP-0460679-A2 | Endothelin antagonistic peptide derivatives | Banyu Pharmaceutical Co., Ltd. (JP) | 1991-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235319-A1 | NEAR-INFRARED LIGHT-EMITTING DIODE AND DEVICE INCLUDING NEAR-INFRARED LIGHT-EMITTING DIODE | OCIAD1, PPOX, OCIAD2 | KDM1A 2185/4885MAOA 1802/4885RCOR1 510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.